REFR:NASDAQResearch Frontiers Incorporated Analysis

Research Frontiers (REFR) is trading at $0.75, barely above its recent support of $0.73, with the 20‑day SMA (0.83) already below the current price, indicating limited short‑term upside. The 14‑day RSI sits at 34, suggesting the stock is oversold but still in a bearish momentum zone, reinforced by a negative MACD histogram and a bearish MACD signal line. Volatility is extreme, with a 30‑day range exceeding 66% and a max drawdown of nearly 69%, while beta is near 1, exposing the equity to market swings. Fundamentals are deeply distressed: revenue has collapsed by 75%, gross margins are negative, and the company reports a negative EBITDA of $‑2.4 M and zero earnings per share. The balance sheet shows a debt‑to‑equity ratio above 60% and a price‑to‑book of 14.7, far above the industry norm, while cash reserves barely cover debt. The recent conference‑call announcements highlight that Q1 2026 results were negatively impacted by timing of royalty recognition, underscoring the earnings volatility. Overall, the market’s “Extreme Greed” sentiment (Fear & Greed Index 91.6) appears disconnected from the underlying financial weakness.
Given the bearish technical profile, deteriorating fundamentals, high valuation multiples, and shrinking volume, the stock presents a high‑risk, short‑term downside bias with limited upside potential unless a material turnaround catalyst emerges.